117 related articles for article (PubMed ID: 2545322)
1. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
Payment P; Trudel M; Thibodeau L; Lecomte J
Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains.
Sawyer LA; McInnis J; Albrecht P
Biologicals; 1993 Jun; 21(2):169-77. PubMed ID: 8297601
[TBL] [Abstract][Full Text] [Related]
4. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
Humphrey DD; Kew OM; Feorino PM
Infect Immun; 1982 May; 36(2):841-3. PubMed ID: 6282759
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies.
Singer C; Knauert F; Bushar G; Klutch M; Lundquist R; Quinnan GV
J Biol Stand; 1989 Apr; 17(2):137-50. PubMed ID: 2541133
[TBL] [Abstract][Full Text] [Related]
7. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
[TBL] [Abstract][Full Text] [Related]
8. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
9. WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.
Ferguson M; Magrath DI; Minor PD; Schild GC
Bull World Health Organ; 1986; 64(2):239-46. PubMed ID: 3017595
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.
Ferguson M; Yi-hua Q; Minor PD; Magrath DI; Spitz M; Schild GC
Lancet; 1982 Jul; 2(8290):122-4. PubMed ID: 6123838
[TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
12. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
Horie H; Sato M; Doi Y; Hashizume S
Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
Nikolaienko IV
Lik Sprava; 1998 May; (3):84-6. PubMed ID: 9695574
[TBL] [Abstract][Full Text] [Related]
14. Development of allogenic hybridomas for production of monoclonal antibodies against oral polio vaccine strains.
Gupta CK; Sokhey J; Gupta RK; Singh H
Vaccine; 1991 Nov; 9(11):853-4. PubMed ID: 1661979
[No Abstract] [Full Text] [Related]
15. Natural variation of poliovirus neutralization epitopes.
Crainic R; Couillin P; Blondel B; Cabau N; Boué A; Horodniceanu F
Infect Immun; 1983 Sep; 41(3):1217-25. PubMed ID: 6193066
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of poliovirus isolates in Canada, 1962-1981.
Furesz J; Armstrong RE; Contreras G; Wachmann B
Rev Infect Dis; 1984; 6 Suppl 2():S528-34. PubMed ID: 6330852
[TBL] [Abstract][Full Text] [Related]
17. Antigenic characterization of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Spitz M; Schild GC
Rev Infect Dis; 1984; 6 Suppl 2():S510-3. PubMed ID: 6204368
[TBL] [Abstract][Full Text] [Related]
18. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
19. Rapid and accurate identification of poliovirus strains used for vaccine production.
Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1985 May; 66 ( Pt 5)():1045-53. PubMed ID: 2987395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
